A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status:
Recruiting
Trial end date:
2024-09-24
Target enrollment:
Participant gender:
Summary
This is a Phase 3, randomized, double-blind, placebo-controlled study to demonstrate the
effect of oral ozanimod as maintenance therapy in subjects with moderately to severely active
Crohn's Disease.